Market Cap: $426.73M
OI
Ovid Therapeutics Inc.
OVID
NASDAQ (NASDAQ Global Select)USD
Market Cap: $426.73M
Ovid Therapeutics Advances Epilepsy Drug Development with Promising Study Results Ovid Therapeutics demonstrates a significant breakthrough in its pursuit of novel therapies for drug-resistant epileps…
Ovid Therapeutics Expands Clinical Trials for Neurological Disorders Ovid Therapeutics, a biopharmaceutical company focused on developing innovative therapies for neurological disorders, recently anno…
Ovid Therapeutics Advances in Pediatric Epilepsy Treatments Ovid Therapeutics is making significant strides in the treatment of pediatric epilepsy, particularly through its development of therapies ai…
Ovid Therapeutics Advances in Rare Genetic Disorders with Promising Clinical Trial Results Ovid Therapeutics is making significant strides in the treatment of rare genetic disorders, particularly focu…
Kennedy’s Nomination Signals Shift in Health Policy In a significant development for public health governance, President-elect Donald Trump nominates Robert F. Kennedy Jr. to lead the Department of He…